ArticleFrontiers in human neuroscience2025
Low perioperative hemoglobin as an independent detrimental predictor of functional outcome after basal ganglia hemorrhage: development and validation of a composite prognostic model.
Article in Frontiers in human neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Basal ganglia hemorrhage (BGH) is a life-threatening neurosurgical emergency associated with substantial mortality and disability. Accurate postoperative prognosis assessment remains challenging due to multifactorial influences. Hemoglobin (HB), as the key determinant of oxygen delivery, may play a critical role in neurological recovery, yet the prognostic significance of perioperative HB fluctuations in BGH has not been fully elucidated. Methods: A retrospective cohort of 213 surgically treated BGH patients from 2020 to 2023 was analyzed. Perioperative HB indices, including preoperative (Pre-HB), postoperative (Post-HB), and mean HB (Mean-HB) levels, were evaluated alongside clinical data. Functional outcome at 6 months was determined based on the modified Rankin Scale (mRS). Least absolute shrinkage and selection operator (LASSO) regression together with multivariate logistic regression models were utilized to screen for independent risk variables, followed by construction of a composite predictive model. Model discrimination, calibration, and evaluation of the model's clinical applicability were conducted using receiver operating characteristic (ROC) analysis, calibration plots, and decision curve analysis (DCA). Results: Patients with poor prognosis exhibited significantly lower Pre-HB, Post-HB, and Mean-HB levels (all Conclusion: Perioperative declines in HB are independently associated with poor postoperative outcomes in BGH. The proposed HB-integrated model provides a reliable, dynamic tool for individualized risk prediction, facilitating precision perioperative management and optimized recovery strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.